Cytomegalovirus reactivation and tumour necrosis factor

The Lancet

Volumn 343, Issue 8892, 1994, Pages 268-269

  Docke W D ^a   Fietze, E ^a   Syrbe, U ^a   von Baehr, R ^a   Volk, H D ^a   Prosch S ^a   Kimel, V ^a   Kruger D H ^a   Zuckermann, H ^a   Klug, C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MONOCLONAL ANTIBODY; OKT 3; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEPSIS; VIRUS REACTIVATION;

EID: 0027977119     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91116-9     Document Type: Article

References (10)

1. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells
2. Impact of cytomegalovirus infection on organ transplant recipients
3. Clinical, diagnostic and physiopathological aspects of cytomegalovirus pneumonia after bone marrow transplantation
4. Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus immediate-early enhancer/promoter in immature monocytic cells
5. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression
6. Cytomegalovirus infection in common variable immunodeficiency
7. Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR
8. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease
9. Serum levels of cytokines in chronic liver diseases
10. Reactivation of cytomegalovirus in patients with cirrhosis: analysis of 122 cases